BeStock  
Stocks › RPRX

Royalty Pharma RPRX

US equityMarket cap rank #487
$57.53 −$0.84 (-1.43%)
Market open · Oct 1, 11:50 am ET · After hours $58.36 0.00%
Open$58.36
Prev close$58.36
Day range$57.44 – $58.40
Volume714.1K
Market cap$25.61B
P/E (TTM)30.9
Dividend yield1.58%

RPRX Stock News

Headlines matching Royalty Pharma or the RPRX ticker, most recent first.

  • Citi Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $70Market news · 9 Sep 2026
  • TD Cowen Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $68Market news · 8 Sep 2026
  • UBS Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $66Market news · 8 Sep 2026
  • Royalty Pharma(RPRX.US) Officer Sells US$5.85 Million in Common StockMarket news · 25 Sep 2026
  • BofA Securities Maintains Royalty Pharma(RPRX.US) With Buy Rating, Announces Target Price $63Market news · 24 Sep 2026
  • Form 144 | Royalty Pharma(RPRX.US) Officer Proposes to Sell 5.85 Million in Common StocksMarket news · 23 Sep 2026
  • Goldman Sachs Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $66Market news · 7 Aug 2026
  • Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $65Market news · 7 Aug 2026
  • Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $65Market news · 6 Aug 2026
  • Citi Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $70Market news · 6 Aug 2026
  • UBS Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $66Market news · 11 Aug 2026
  • J.P. Morgan Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $62Market news · 11 Aug 2026
  • Citi Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $66Market news · 16 Jul 2026
  • TD Cowen Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $65Market news · 13 Jul 2026
  • BofA Securities Maintains Royalty Pharma(RPRX.US) With Buy RatingMarket news · 10 Jul 2026

Discussion

No comments yet — be the first to weigh in on RPRX.

Leave a comment

Scroll to Top